Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain

Objectives: The aim of this study was to identify factors that predict recurrence by comparing low-dose and standard-dose Bacillus Calmette-Guérin (BCG) induction therapy in patients with non-muscle invasive bladder cancer (NMIBC). Methods: A total of 273 consecutive NMIBC patients who received low-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hideyuki Isobe, Fumitaka Shimizu, Takeshi Ieda, So Nakamura, Naoko Takazawa, Hanna Suetsugu, Kazunori Kajino, Shu Hirai, Hisashi Hirano, Katsuhito Yuzawa, Shigeo Horie
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Biomedicines
Subjects:	non-muscle invasive bladder cancer low-dose BCG standard-dose BCG intravesical induction therapy
Online Access:	https://www.mdpi.com/2227-9059/13/1/174
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain

Similar Items